Skip to main content

Peer Review reports

From: Long-term outcomes of edaravone in amyotrophic lateral sclerosis in South Korea: 72-week observational study

Original Submission
12 Jan 2022 Submitted Original manuscript
14 Feb 2022 Reviewed Reviewer Report
7 Mar 2022 Reviewed Reviewer Report
20 Mar 2022 Author responded Author comments - Jin-Mo Park
Resubmission - Version 2
20 Mar 2022 Submitted Manuscript version 2
16 Jun 2022 Reviewed Reviewer Report
28 Jun 2022 Author responded Author comments - Jin-Mo Park
Resubmission - Version 3
28 Jun 2022 Submitted Manuscript version 3
Publishing
7 Jul 2022 Editorially accepted
14 Jul 2022 Article published 10.1186/s12883-022-02788-x

You can find further information about peer review here.

Back to article page